JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bochelen, D.
Right arrow Articles by Sauter, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bochelen, D.
Right arrow Articles by Sauter, A.

Vol. 288, Issue 2, 653-659, February 1999

Calcineurin Inhibitors FK506 and SDZ ASM 981 Alleviate the Outcome of Focal Cerebral Ischemic/Reperfusion Injury

D. Bochelen, M. Rudin and A. Sauter

Novartis Pharma A.G., Basel, Switzerland

The neuroprotective properties of drugs binding to FKBP12, with and without subsequent inhibition of calcineurin, were investigated in rat models of ischemic embolic stroke. Drug effects on brain infarct volumes evoked by transient middle cerebral artery occlusion (MCAO) and by permanent MCAO were determined in vivo by T2-weighted magnetic resonance imaging and post mortem by triphenyltetrazolium chloride staining and histology. Drugs binding to FKBP12 and inhibiting calcineurin, such as FK506 and SDZ ASM 981, dose dependently reduced the infarct volumes, determined 48 h after MCAO by both magnetic resonance imaging and triphenyltetrazolium chloride staining but only in the transient MCAO model. In vivo potencies to reduce brain infarcts paralleled the in vitro potencies to inhibit calcineurin. Histological staining after 6 days of survival showed that the neuroprotective effects were permanent. Rapamycin, known to bind with similar affinity to FKBP12 but not to inhibit calcineurin, was not neuroprotective but abolished the neuroprotective effects of FK506 when coadministered. In the permanent MCAO models, FK506 showed no effect when injected before and little effect when injected after MCAO. Measurements of core temperatures after MCAO in controls and drug-treated rats do not support hypothermia being the mechanism responsible for neuroprotection. We conclude that drugs inhibiting calcineurin activity are neuroprotective in focal cerebral ischemia/reperfusion but not in permanent ischemia models, possibly by preventing reperfusion injury.

0022-3565/99/2882-0653$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
F. Edlich, M. Weiwad, D. Wildemann, F. Jarczowski, S. Kilka, M.-C. Moutty, G. Jahreis, C. Lucke, W. Schmidt, F. Striggow, et al.
The Specific FKBP38 Inhibitor N-(N',N'-Dimethylcarboxamidomethyl)cycloheximide Has Potent Neuroprotective and Neurotrophic Properties in Brain Ischemia
J. Biol. Chem., May 26, 2006; 281(21): 14961 - 14970.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
G. Yilmaz, T. V. Arumugam, K. Y. Stokes, and D. N. Granger
Role of T Lymphocytes and Interferon-{gamma} in Ischemic Stroke
Circulation, May 2, 2006; 113(17): 2105 - 2112.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
T. Omura, Y. Tanaka, N. Miyata, C. Koizumi, T. Sakurai, M. Fukasawa, K. Hachiuma, T. Minagawa, T. Susumu, S. Yoshida, et al.
Effect of a New Inhibitor of the Synthesis of 20-HETE on Cerebral Ischemia Reperfusion Injury
Stroke, May 1, 2006; 37(5): 1307 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Huang, J. B. Fileta, A. Dobberfuhl, T. Filippopolous, Y. Guo, G. Kwon, and C. L. Grosskreutz
Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma
PNAS, August 23, 2005; 102(34): 12242 - 12247.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Tachibana, N. Shiiya, T. Kunihara, Y. Wakamatsu, A. F. Kudo, T. Ooka, S. Watanabe, and K. Yasuda
Immunophilin ligands FK506 and cyclosporine A improve neurologic and histopathologic outcome after transient spinal cord ischemia in rabbits
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 123 - 128.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. Bolay, Y. Gursoy-Ozdemir, Y. Sara, R. Onur, A. Can, and T. Dalkara
Persistent Defect in Transmitter Release and Synapsin Phosphorylation in Cerebral Cortex After Transient Moderate Ischemic Injury
Stroke, May 1, 2002; 33(5): 1369 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
H. Takamatsu, H. Tsukada, A. Noda, T. Kakiuchi, S. Nishiyama, S. Nishimura, and K. Umemura
FK506 Attenuates Early Ischemic Neuronal Death in a Monkey Model of Stroke
J. Nucl. Med., December 1, 2001; 42(12): 1833 - 1840.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. E. Springer, R. D. Azbill, S. A. Nottingham, and S. E. Kennedy
Calcineurin-Mediated BAD Dephosphorylation Activates the Caspase-3 Apoptotic Cascade in Traumatic Spinal Cord Injury
J. Neurosci., October 1, 2000; 20(19): 7246 - 7251.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.